Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 billion. The acquisition – which was confirmed to be in the final stages of ...
Germany's Merck KGaA is looking at making further acquisitions to boost its business, according to chief executive Belén Garijo. The CEO – who is due to step down next April after five years in the ...
It’s been a wonderful season for snow-related schadenfreude here in Florida, where even with the plummeting temps and iguanas, we use our shovels for sandcastles and our salt for margaritas. But ...
The investment seeks to provide investors with an opportunity to invest in gold through the shares and be able to take delivery of physical gold in exchange for those shares. The Trust’s secondary ...
There is no recent news for this security. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your ...
Copyright © 2026 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...
PT Merck Tbk engages in the pharmaceutical and chemical businesses. It operates through the following segments: Biopharma, Consumer Health, and Others. The Biopharma segment offers ethical products.
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results